Trade Names:
Status: Approved
Entry Type: Combination
Molecule Category: Mixture
Compounds in the Mixture: COBICISTAT ELVITEGRAVIR EMTRICITABINE TENOFOVIR ALAFENAMIDE FUMARATE

Related Entries

Parent
Parent
Parent
Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
10.38
Investigations
10.0
Injury, poisoning and procedural complications
9.74
Gastrointestinal disorders
7.77
Nervous system disorders
6.95
Psychiatric disorders
5.96
Metabolism and nutrition disorders
4.7
Skin and subcutaneous tissue disorders
4.65
Musculoskeletal and connective tissue disorders
4.17
Infections and infestations
3.94
Cardiac disorders
3.89
Vascular disorders
3.78
Renal and urinary disorders
3.66
Respiratory, thoracic and mediastinal disorders
3.48
Pregnancy, puerperium and perinatal conditions
3.35
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.05
Immune system disorders
2.02